You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Challenges and Opportunities in Achieving Treat-to-Target in Psoriatic Arthritis

  • Authors: Laura Coates, MD, PhD; Laure Gossec, MD, PhD; Philip Mease, MD, MACR
  • CPD Released: 7/26/2022
  • Valid for credit through: 7/26/2023
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 0.50 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for an international audience of rheumatologists, dermatologists, and primary care physicians.

The goal of this activity is that learners will be better able to implement T2T strategies for patients with PsA in clinical practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Monitoring of PsA using objective disease activity measures
    • Treatment targets in the management of PsA
  • Have greater competence related to
    • Implementing T2T for PsA in daily clinical practice


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Faculty

  • Laura Coates, MD, PhD

    Associate Professor
    University of Oxford
    Oxford, United Kingdom

    Disclosures

    Laura Coates, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Amgen; Boehringer Ingelheim; Bristol Myers Squibb; Celgene; Eli Lilly; Gilead Sciences; Galapagos; Janssen; Novartis; Pfizer; UCB
    Speaker or member of speakers bureau for: AbbVie; Amgen; Biogen; Celgene; Eli Lilly; Galapagos; Gilead Sciences; Janssen; Medac; Novartis; Pfizer; UCB
    Research funding from: AbbVie; Amgen; Celgene; Eli Lilly; Novartis; Pfizer

  • Laure Gossec, MD, PhD

    Professor of Rheumatology
    Sorbonne Université
    Pitié-Salpêtrière Hospital
    Paris, France

    Disclosures

    Laure Gossec, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Amgen; Bristol Myers Squibb; Eli Lilly; Galapagos; Gilead; GlaxoSmithKline; Janssen; Novartis; Pfizer; Samsung Bioepis; Sanofi-Aventis; UCB
    Research funding from: Amgen; Eli Lilly; Galapagos; Pfizer; Sandoz

  • Philip Mease, MD, MACR

    Clinical Professor
    University of Washington School of Medicine
    Director, Rheumatology Research
    Swedish Medical Center/Providence St. Joseph Health
    Seattle, WA, United States

    Disclosures

    Philip Mease, MD, MACR, has the following relevant financial relationships:
    Consultant or advisor for: AbbVie; Amgen; Boehringer Ingelheim; Bristol Myers Squibb; Eli Lilly; Galapagos; Gilead Sciences; GlaxoSmithKline; Janssen; Novartis; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB
    Speaker or member of speakers bureau for: AbbVie; Amgen; Eli Lilly; Janssen; Novartis; Pfizer; UCB
    Research funding from: AbbVie; Amgen; Bristol Myers Squibb; Eli Lilly; Galapagos; Gilead Sciences; Janssen; Novartis; Pfizer; Sun Pharmaceutical Industries Ltd.; UCB

Editors

  • Marinella Calle, PhD, CMPP

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Marinella Calle, PhD, CMPP, has no relevant financial relationships.

  • Diana Lucifero, PhD

    Scientific Content Manager, WebMD Global, LLC

    Disclosures

    Diana Lucifero, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Susan L. Smith, MN, PhD

    Associate Director, Accreditation and Compliance

    Disclosures

    Susan L. Smith, MN, PhD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Challenges and Opportunities in Achieving Treat-to-Target in Psoriatic Arthritis

Authors: Laura Coates, MD, PhD; Laure Gossec, MD, PhD; Philip Mease, MD, MACRFaculty and Disclosures

CPD Released: 7/26/2022

Valid for credit through: 7/26/2023

processing....

Commentaire d'expert en français

Ce commentaire fait partie d’une activité de formation plus vaste. Après la participation, prière de retourner à  Challenges and Opportunities in Achieving Treat-to-Target in Psoriatic Arthritis  pour accéder à l’ensemble du contenu de formation relié.  

 
« Return to: Challenges and Opportunities in Achieving Treat-to-Target in Psoriatic Arthritis